Report cover image

Pharmaceuticals - Enterprise ICT

Publisher GlobalData
Published Dec 24, 2025
Length 54 Pages
SKU # GBDT21015397

Description

Pharmaceuticals - Enterprise ICT

Summary

The Pharmaceuticals Enterprise ICT Country Intelligence Report, a new Vertical Intelligence Report by GlobalData, summarizes key findings from GlobalData’s ICT Customer Insight Survey carried out in H1-2025 and GlobalData’s Market Opportunity Forecasts to 2029. It reveals an executive-level overview of how the overall ICT budgets and their allocations towards various segments have changed for enterprises in the vertical in 2025 compared to 2024 and ICT revenue opportunity with detailed forecasts of key indicators up to 2029. The report provides detailed analysis of the overall Pharmaceuticals enterprise ICT market trends and growth drivers based on GlobalData’s ICT Customer Insight Survey and GlobalData’s Market Opportunity Forecasts. The report also discusses about the market growth inhibitors impacting Pharmaceuticals overall ICT market. It sheds focus on enterprise ICT budget allocations and ICT revenue opportunity covering 18 solution areas, segmental analysis, and regional analysis. The report also includes a brief profile on some of the key ICT vendors within the Pharmaceuticals vertical.

The vertical intelligence provides information and insights into ICT budget allocations and ICT revenue opportunity by enterprises in Pharmaceutical vertical
  • Overall enterprise ICT revenue opportunity and ICT budget allocations for Pharmaceuticals
  • Insights on Pharmaceuticals enterprise ICT growth drivers and market trends, basis GlobalData's ICT Customer Insight Survey and Market Oppotunity Forecasts to 2029
  • Insights on market growth inhibitors impacting Pharmaceuticals's overall ICT market
  • Breakdown of enterprise ICT revenue opportunity by solution areas, segments and regions
  • Segmental analysis of Pharmaceuticals enterprise ICT budget allocations and ICT revenue opportunity - hardware, software and services
  • Insights on ICT technology spending priorities of enterprises on key solution areas in Pharmaceuticals
  • Company snapshot
Key Highlights
  • The total ICT revenue opportunity in the Pharmaceuticals vertical is expected to rise from over $100 billion in 2024 to over $200 billion by 2029 driven by rising ICT budgets of pharma companies, investments and partnerships with tech startups, and the increasing use of advanced technology in research & development (R&D).
  • These findings have been corroborated by GlobalData’s ICT survey in which more than 90% have stated their ICT budgets have increased in 2025 as compared to 2024.
  • In terms of ICT revenue opportunity in the Pharmaceuticals vertical by IT infrastructure, IT services held the highest share in 2024 followed by IT software and IT hardware. However, revenue opportunity in IT software is expected to grow at the fastest pace during 2024-2029.
  • North America, Asia-Pacific, and Western Europe are top three regional markets for ICT in the Pharmaceuticals vertical.
  • Investments in AI are expected to grow at the fastest pace during 2024-2029, followed by edge computing and cloud computing. These technologies enable pharma companies to enhance operational efficiency and improve drug discovery, clinical trials, and manufacturing.
Scope
  • The vertical intelligence report provides an in-depth analysis of the following enterprise ICT market outlook, enterprise ICT budget allocations, enterprise ICT segment revenue and budget allocations, enterprise ICT market dynamics, enterprise technology priorities and ICT vendor landscape.
Reasons to Buy
  • This Vertical Intelligence Report is based on GlobalData’s IT Customer Insight Survey carried out annually covering key ICT decision makers from enterprises across various solution areas in Pharmaceuticals and GlobalData’s Market Opportunity Forecasts to 2029, to offer a thorough, forward-looking analysis of Pharmaceuticals enterprise ICT investment priorities and ICT revenue opportunity market.
  • Accompanying GlobalData’s IT Customer Insight Survey and Market Opportunity Forecasts to 2029, the report examines the assumptions and drivers behind ongoing and upcoming trends in Pharmaceuticals enterprise ICT market.
  • The report offers a thorough analysis of enterprise ICT investment trends and how it has changed this year compared to previous year.
  • The report also presents an analysis of enterprise ICT budget allocations by various spending areas, business functions and product/service categories and how they have changed this year compared to previous years.
  • The report also presents an analysis of enterprise ICT revenue opportunity by various solution areas, regions, and segment over the forecast period 2024-2029.
  • With more than 50 charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides insights in a concise format to help executives build proactive and profitable growth strategies.
  • The report provides an easily digestible market assessment for decision-makers built around research gathered from the local IT decision makers, which enables executives to quickly get up to speed with the current and emerging trends in enterprise ICT investment priorities.

Table of Contents

54 Pages
Enterprise ICT Market in Pharmaceuticals Vertical Highlights
Survey Demographics
ICT in Pharmaceuticals Vertical Market Overview
Market Dynamics
ICT Market by Infrastructure Segments
Enterprise Investment Priorities in Key Solution Areas
Enterprise Invetsment Priorities across Key Regions
Company Snapshot
Appendix

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us